Skip to main content

Table 1 Characteristics of the patients at baseline

From: Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

Characteristics Patients (n = 459)
Sex (men/women) n (%) 310/149 (67.5 / 32.5)
Age (year) (± SD) 65.6 (± 13.7)
Weight (± SD) 85.5 (± 22.2)
Chronic renal failurea n (%) 43 (9)
Congestive heart failure n (%) 41 (9)
Ischemic heart disease n (%) 43 (9)
Hypertension n (%) 235 (51)
Diabetes mellitus n (%) 121 (26)
Invasive mechanical ventilation n (%) 394 (86)
ARDSb n (%) 156/456 (34)
SAPS IIIc (± SD) 73.4 (± 14.0)
SOFAd (± SD) 11.2 (± 3.0)
Central venous catheter n (%) 411 (90)
  1. All data at enrollment. Plus–minus values are means ± SD (standard deviation)
  2. aChronic renal failure defined as eGFR < 60 ml/mn
  3. bARDS: Berlin definition
  4. cThe Simplified Acute Physiology Score (SAPS) III ranges from 0 to 146, with higher scores indicating more severe disease and a higher risk of death
  5. dThe Sepsis‐related Organ Failure Assessment (SOFA) score ranges from 0 to 24, with higher scores indicating more severe organ failure